Casodex vs Placebo in Non-Metastatic Early Prostate Cancer

NCT00672282 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1218

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Metastatic Prostate Cancer

Interventions

DRUG: Bicalutamide
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]